HomeAI · summaries
Storia in 6 fonti
Novo asks court to block Lilly ads; Merck strikes HIV PrEP deal
Novo Nordisk sues Eli Lilly over misleading ads; Merck licenses alimatravir; AbbVie/Genmab clarify Epkinly trial; J&J touts Talvey/Tecvayli data; MannKind gets FDA nod.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cbsnews.com
Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
- ·
channelnewsasia.com
Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads
Novo Nordisk said Eli Lilly's ads uses outdated research and leave out important information, which could mislead consumers.
